Bioventus
Mark Singleton serves as the Company’s Senior Vice President, Chief Financial Officer and Principle Accounting Officer.
Mr. Singleton has more than two decades of experience in operational finance and mergers & acquisitions at large and multi-national organizations. Mark was also involved in initiating the Vascular Solutions acquisition which became a separate business unit at Teleflex.
Previous to this role, Mr. Singleton served as Vice President of Finance of Teleflex’s Vascular business where he had financial responsibility for the $1.7 billion Americas business. Prior to Teleflex, he spent nearly two decades at Lenovo/IBM, where he held a number of senior leadership positions, including EMEA CFO, Western Europe CFO, North America CFO, and Think Business Group CFO.
Mr. Singleton earned his Master of Business Administration from Duke University’s Fuqua School of Business and completed his Bachelor of Science in Finance from Purdue University.
This person is not in any offices
Bioventus
4 followers
Bioventus® is a global leader in orthobiologics and its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus accomplishes this with its orthobiologic solutions for musculoskeletal healing and regeneration that engage and enhance the body’s healing process. The company has products for bone healing, bone graft and knee osteoarthritis. Established in 2012, Bioventus is privately held and headquartered in Durham, NC. The company has more than 700 employees worldwide and its international headquarters is in Hoofddorp, The Netherlands. Bioventus also has offices in Memphis, TN and Toronto, Ontario, Canada. Bioventus works with patients, payers and health care providers throughout the world, and generates $300 million dollars in yearly revenue.